COXPD15
MCID: CMB048
MIFTS: 20

Combined Oxidative Phosphorylation Deficiency 15 (COXPD15)

Categories: Genetic diseases, Metabolic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Combined Oxidative Phosphorylation Deficiency 15

MalaCards integrated aliases for Combined Oxidative Phosphorylation Deficiency 15:

Name: Combined Oxidative Phosphorylation Deficiency 15 58 76 30 13 6 74
Coxpd15 58 60 76
Combined Oxidative Phosphorylation Deficiency, Type 15 41
Combined Oxidative Phosphorylation Defect Type 15 60

Characteristics:

Orphanet epidemiological data:

60
combined oxidative phosphorylation defect type 15
Prevalence: <1/1000000 (Worldwide); Age of onset: Childhood,Infancy; Age of death: early childhood,late childhood;

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
highly variable phenotype
onset in childhood


HPO:

33
combined oxidative phosphorylation deficiency 15:
Onset and clinical course phenotypic variability
Inheritance autosomal recessive inheritance


Classifications:

Orphanet: 60  
Inborn errors of metabolism


Summaries for Combined Oxidative Phosphorylation Deficiency 15

UniProtKB/Swiss-Prot : 76 Combined oxidative phosphorylation deficiency 15: An autosomal recessive, mitochondrial, neurologic disorder characterized by features of Leigh syndrome and combined oxidative phosphorylation deficiency. Clinical features include mild global developmental delay, white matter abnormalities, ataxia, incoordination, speech and reading difficulties, T2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem.

MalaCards based summary : Combined Oxidative Phosphorylation Deficiency 15, is also known as coxpd15, and has symptoms including ataxia An important gene associated with Combined Oxidative Phosphorylation Deficiency 15 is MTFMT (Mitochondrial Methionyl-TRNA Formyltransferase). Related phenotypes are obesity and nystagmus

Description from OMIM: 614947

Related Diseases for Combined Oxidative Phosphorylation Deficiency 15

Symptoms & Phenotypes for Combined Oxidative Phosphorylation Deficiency 15

Human phenotypes related to Combined Oxidative Phosphorylation Deficiency 15:

33 (show all 22)
# Description HPO Frequency HPO Source Accession
1 obesity 33 occasional (7.5%) HP:0001513
2 nystagmus 33 occasional (7.5%) HP:0000639
3 seizures 33 occasional (7.5%) HP:0001250
4 ataxia 33 occasional (7.5%) HP:0001251
5 tremor 33 occasional (7.5%) HP:0001337
6 microcephaly 33 occasional (7.5%) HP:0000252
7 optic atrophy 33 occasional (7.5%) HP:0000648
8 short stature 33 occasional (7.5%) HP:0004322
9 strabismus 33 occasional (7.5%) HP:0000486
10 reduced visual acuity 33 occasional (7.5%) HP:0007663
11 wolff-parkinson-white syndrome 33 occasional (7.5%) HP:0001716
12 increased serum lactate 33 occasional (7.5%) HP:0002151
13 ventricular septal defect 33 occasional (7.5%) HP:0001629
14 generalized hypotonia 33 occasional (7.5%) HP:0001290
15 abnormal pyramidal sign 33 occasional (7.5%) HP:0007256
16 global developmental delay 33 HP:0001263
17 delayed speech and language development 33 HP:0000750
18 cognitive impairment 33 HP:0100543
19 incoordination 33 HP:0002311
20 unsteady gait 33 HP:0002317
21 increased csf lactate 33 HP:0002490
22 abnormality of the cerebral white matter 33 HP:0002500

Symptoms via clinical synopsis from OMIM:

58
Neurologic Central Nervous System:
ataxia
global developmental delay
cognitive impairment
incoordination
seizures (rare)
more
Head And Neck Eyes:
optic atrophy (in some patients)
nystagmus (in some patients)
decreased visual acuity (in some patients)
strabismus (in some patients)

Growth Height:
short stature (in some patients)

Muscle Soft Tissue:
hypotonia (in some patients)

Laboratory Abnormalities:
increased csf lactate
increased serum lactate (in some patients)
patient fibroblasts and muscle show decreased activities of mitochondrial complexes i, iii, and iv
impaired mitochondrial translation

Cardiovascular Heart:
ventricular septal defect (in some patients)
wolff-parkinson-white syndrome (in some patients)
ventricular septal hypertrophy (in some patients)

Head And Neck Head:
microcephaly (in some patients)

Growth Weight:
obesity (in some patients)

Clinical features from OMIM:

614947

UMLS symptoms related to Combined Oxidative Phosphorylation Deficiency 15:


ataxia

Drugs & Therapeutics for Combined Oxidative Phosphorylation Deficiency 15

Search Clinical Trials , NIH Clinical Center for Combined Oxidative Phosphorylation Deficiency 15

Genetic Tests for Combined Oxidative Phosphorylation Deficiency 15

Genetic tests related to Combined Oxidative Phosphorylation Deficiency 15:

# Genetic test Affiliating Genes
1 Combined Oxidative Phosphorylation Deficiency 15 30 MTFMT

Anatomical Context for Combined Oxidative Phosphorylation Deficiency 15

Publications for Combined Oxidative Phosphorylation Deficiency 15

Variations for Combined Oxidative Phosphorylation Deficiency 15

UniProtKB/Swiss-Prot genetic disease variations for Combined Oxidative Phosphorylation Deficiency 15:

76
# Symbol AA change Variation ID SNP ID
1 MTFMT p.Ser125Leu VAR_069303 rs397514614
2 MTFMT p.Ser209Leu VAR_069304 rs201431517

ClinVar genetic disease variations for Combined Oxidative Phosphorylation Deficiency 15:

6 (show all 28)
# Gene Variation Type Significance SNP ID Assembly Location
1 MTFMT NM_139242.3(MTFMT): c.1116delT (p.Pro373Glnfs) deletion Likely pathogenic rs863224897 GRCh37 Chromosome 15, 65295454: 65295454
2 MTFMT NM_139242.3(MTFMT): c.1116delT (p.Pro373Glnfs) deletion Likely pathogenic rs863224897 GRCh38 Chromosome 15, 65003116: 65003116
3 MTFMT NM_139242.3(MTFMT): c.626C> T (p.Ser209Leu) single nucleotide variant Pathogenic/Likely pathogenic rs201431517 GRCh37 Chromosome 15, 65313871: 65313871
4 MTFMT NM_139242.3(MTFMT): c.626C> T (p.Ser209Leu) single nucleotide variant Pathogenic/Likely pathogenic rs201431517 GRCh38 Chromosome 15, 65021533: 65021533
5 MTFMT NM_139242.3(MTFMT): c.382C> T (p.Arg128Ter) single nucleotide variant Pathogenic rs397514613 GRCh37 Chromosome 15, 65319206: 65319206
6 MTFMT NM_139242.3(MTFMT): c.382C> T (p.Arg128Ter) single nucleotide variant Pathogenic rs397514613 GRCh38 Chromosome 15, 65026868: 65026868
7 MTFMT NM_139242.3(MTFMT): c.374C> T (p.Ser125Leu) single nucleotide variant Pathogenic rs397514614 GRCh37 Chromosome 15, 65319214: 65319214
8 MTFMT NM_139242.3(MTFMT): c.374C> T (p.Ser125Leu) single nucleotide variant Pathogenic rs397514614 GRCh38 Chromosome 15, 65026876: 65026876
9 MTFMT NM_139242.3(MTFMT): c.994C> T (p.Arg332Ter) single nucleotide variant Pathogenic rs200286768 GRCh37 Chromosome 15, 65295576: 65295576
10 MTFMT NM_139242.3(MTFMT): c.994C> T (p.Arg332Ter) single nucleotide variant Pathogenic rs200286768 GRCh38 Chromosome 15, 65003238: 65003238
11 MTFMT NM_139242.3(MTFMT): c.452C> T (p.Pro151Leu) single nucleotide variant Pathogenic rs587777244 GRCh38 Chromosome 15, 65023762: 65023762
12 MTFMT NM_139242.3(MTFMT): c.452C> T (p.Pro151Leu) single nucleotide variant Pathogenic rs587777244 GRCh37 Chromosome 15, 65316100: 65316100
13 MTFMT NM_139242.3(MTFMT): c.146_153delGGGTGCTC (p.Arg49Leufs) deletion Likely pathogenic rs587777417 GRCh38 Chromosome 15, 65029461: 65029468
14 MTFMT NM_139242.3(MTFMT): c.146_153delGGGTGCTC (p.Arg49Leufs) deletion Likely pathogenic rs587777417 GRCh37 Chromosome 15, 65321799: 65321806
15 MTFMT NM_139242.3(MTFMT): c.878G> A (p.Ser293Asn) single nucleotide variant Pathogenic rs587777418 GRCh38 Chromosome 15, 65006127: 65006127
16 MTFMT NM_139242.3(MTFMT): c.878G> A (p.Ser293Asn) single nucleotide variant Pathogenic rs587777418 GRCh37 Chromosome 15, 65298465: 65298465
17 MTFMT NM_139242.3(MTFMT): c.73C> T (p.Gln25Ter) single nucleotide variant Pathogenic rs587777419 GRCh38 Chromosome 15, 65029541: 65029541
18 MTFMT NM_139242.3(MTFMT): c.73C> T (p.Gln25Ter) single nucleotide variant Pathogenic rs587777419 GRCh37 Chromosome 15, 65321879: 65321879
19 MTFMT NM_139242.3(MTFMT): c.219_222delAGAA (p.Glu74Lysfs) deletion Pathogenic rs777725264 GRCh37 Chromosome 15, 65319366: 65319369
20 MTFMT NM_139242.3(MTFMT): c.219_222delAGAA (p.Glu74Lysfs) deletion Pathogenic rs777725264 GRCh38 Chromosome 15, 65027028: 65027031
21 MTFMT NM_139242.3(MTFMT): c.172T> A (p.Phe58Ile) single nucleotide variant Likely benign rs188718836 GRCh37 Chromosome 15, 65321780: 65321780
22 MTFMT NM_139242.3(MTFMT): c.172T> A (p.Phe58Ile) single nucleotide variant Likely benign rs188718836 GRCh38 Chromosome 15, 65029442: 65029442
23 MTFMT NM_139242.3(MTFMT): c.91C> T (p.Arg31Ter) single nucleotide variant Pathogenic rs1555404423 GRCh37 Chromosome 15, 65321861: 65321861
24 MTFMT NM_139242.3(MTFMT): c.91C> T (p.Arg31Ter) single nucleotide variant Pathogenic rs1555404423 GRCh38 Chromosome 15, 65029523: 65029523
25 MTFMT NM_139242.3(MTFMT): c.1100_1101delTT (p.Phe367Serfs) deletion Pathogenic rs754222633 GRCh37 Chromosome 15, 65295469: 65295470
26 MTFMT NM_139242.3(MTFMT): c.1100_1101delTT (p.Phe367Serfs) deletion Pathogenic rs754222633 GRCh38 Chromosome 15, 65003131: 65003132
27 MTFMT NM_139242.3(MTFMT): c.19C> G (p.Arg7Gly) single nucleotide variant Uncertain significance rs759489465 GRCh37 Chromosome 15, 65321933: 65321933
28 MTFMT NM_139242.3(MTFMT): c.19C> G (p.Arg7Gly) single nucleotide variant Uncertain significance rs759489465 GRCh38 Chromosome 15, 65029595: 65029595

Expression for Combined Oxidative Phosphorylation Deficiency 15

Search GEO for disease gene expression data for Combined Oxidative Phosphorylation Deficiency 15.

Pathways for Combined Oxidative Phosphorylation Deficiency 15

GO Terms for Combined Oxidative Phosphorylation Deficiency 15

Sources for Combined Oxidative Phosphorylation Deficiency 15

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....